DRD2 activation inhibits choroidal neovascularization in patients with Parkinson's disease and age-related macular degeneration.

Autor: Mathis T; Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.; Hopital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.; UMR-CNRS 5510, MATEIS, Institut National des Sciences Appliquées, Université Lyon 1, Campus de la Doua, Villeurbanne, France., Baudin F; Service d'ophtalmologie, CHU Dijon, Dijon, France.; Ramsaysanté, Clinique d'Argonay, Argonay, France., Mariet AS; Service de Biostatistiques et D'Information Médicale (DIM), CHU Dijon Bourgogne, INSERM, Université de Bourgogne, CIC 1432, Module Épidémiologie Clinique, Dijon, France., Augustin S; Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France., Bricout M; Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.; Hopital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.; UMR-CNRS 5510, MATEIS, Institut National des Sciences Appliquées, Université Lyon 1, Campus de la Doua, Villeurbanne, France., Przegralek L; Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France., Roubeix C; Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France., Benzenine É; Service de Biostatistiques et D'Information Médicale (DIM), CHU Dijon Bourgogne, INSERM, Université de Bourgogne, CIC 1432, Module Épidémiologie Clinique, Dijon, France., Blot G; Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France., Nous C; Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France., Kodjikian L; Hopital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.; UMR-CNRS 5510, MATEIS, Institut National des Sciences Appliquées, Université Lyon 1, Campus de la Doua, Villeurbanne, France., Mauget-Faÿsse M; Fondation Ophtalmologique Adolphe de Rothschild, Paris, France., Sahel JA; Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.; Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.; Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Plevin R; Strathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom., Zeitz C; Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France., Delarasse C; Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France., Guillonneau X; Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France., Creuzot-Garcher C; Service d'ophtalmologie, CHU Dijon, Dijon, France., Quantin C; Service de Biostatistiques et D'Information Médicale (DIM), CHU Dijon Bourgogne, INSERM, Université de Bourgogne, CIC 1432, Module Épidémiologie Clinique, Dijon, France.; Université Paris-Saclay, University of Versailles Saint-Quentin-en-Yvelines (UVSQ), INSERM, Centre for Epidemiology and Population Health (CESP), Villejuif, France., Hunot S; Sorbonne Université, Paris Brain Institute-L'Institut du Cerveau, INSERM, CNRS, Hôpital de la Pitié Salpêtrière, Paris., Sennlaub F; Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2024 Jul 16; Vol. 134 (17). Date of Electronic Publication: 2024 Jul 16.

Thérapie cellulaire par cellules souches mésenchymateuses, un nouvel espoir pour les pathologies oculaires

Autor: Roubeix, C., Denoyer, A., Brignole-Baudouin, F., Baudouin, C.

Publikováno v: In Journal Francais d'Ophtalmologie October 2015 38(8):764-775

FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degeneration.

Autor: Alfaar AS; Experimental Ophthalmology, Department of Ophthalmology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität, Berlin Institute of Health, Humboldt-University, 10117, Berlin, Germany.; Department of Ophthalmology, University Hospital of Ulm, 89075, Ulm, Germany., Stürzbecher L; Experimental Ophthalmology, Department of Ophthalmology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität, Berlin Institute of Health, Humboldt-University, 10117, Berlin, Germany., Diedrichs-Möhring M; Section of Immunobiology, Department of Ophthalmology, University Hospital, LMU Munich, 80336, Munich, Germany., Lam M; Institut de La Vision, Sorbonne Université, INSERM, CNRS, 75012, Paris, France., Roubeix C; Institut de La Vision, Sorbonne Université, INSERM, CNRS, 75012, Paris, France., Ritter J; Institut Für Med. Mikrobiologie, Immunologie Und Hygiene, TU München, 81675, Munich, Germany., Schumann K; Institut Für Med. Mikrobiologie, Immunologie Und Hygiene, TU München, 81675, Munich, Germany., Annamalai B; Department of Ophthalmology, College of Medicine, Medical University South Carolina, Charleston, SC, 29425, USA., Pompös IM; Experimental Ophthalmology, Department of Ophthalmology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität, Berlin Institute of Health, Humboldt-University, 10117, Berlin, Germany., Rohrer B; Department of Ophthalmology, College of Medicine, Medical University South Carolina, Charleston, SC, 29425, USA., Sennlaub F; Institut de La Vision, Sorbonne Université, INSERM, CNRS, 75012, Paris, France., Reichhart N; Experimental Ophthalmology, Department of Ophthalmology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität, Berlin Institute of Health, Humboldt-University, 10117, Berlin, Germany., Wildner G; Section of Immunobiology, Department of Ophthalmology, University Hospital, LMU Munich, 80336, Munich, Germany. Gerhild.Wildner@med.uni-muenchen.de., Strauß O; Experimental Ophthalmology, Department of Ophthalmology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität, Berlin Institute of Health, Humboldt-University, 10117, Berlin, Germany. Olaf.strauss@charite.de.

Publikováno v: Journal of neuroinflammation [J Neuroinflammation] 2022 Oct 22; Vol. 19 (1), pp. 260. Date of Electronic Publication: 2022 Oct 22.

Hypoxia Inhibits Subretinal Inflammation Resolution Thrombospondin-1 Dependently.

Autor: Touhami S; Institut de la Vision, Sorbonne Université, INSERM, CNRS, 75012 Paris, France.; Ophthalmology Department, Pitié Salpêtrière University Hospital, Sorbonne Université, AP-HP, 75013 Paris, France., Béguier F; Institut de la Vision, Sorbonne Université, INSERM, CNRS, 75012 Paris, France., Yang T; Institut de la Vision, Sorbonne Université, INSERM, CNRS, 75012 Paris, France., Augustin S; Institut de la Vision, Sorbonne Université, INSERM, CNRS, 75012 Paris, France., Roubeix C; Institut de la Vision, Sorbonne Université, INSERM, CNRS, 75012 Paris, France., Blond F; Institut de la Vision, Sorbonne Université, INSERM, CNRS, 75012 Paris, France., Conart JB; Institut de la Vision, Sorbonne Université, INSERM, CNRS, 75012 Paris, France.; Department of Ophthalmology, University Hospital, 54000 Nancy, France., Sahel JA; Institut de la Vision, Sorbonne Université, INSERM, CNRS, 75012 Paris, France.; CHNO des Quinze-Vingts, INSERM-DGOS CIC 1423, 75012 Paris, France., Bodaghi B; Ophthalmology Department, Pitié Salpêtrière University Hospital, Sorbonne Université, AP-HP, 75013 Paris, France., Delarasse C; Institut de la Vision, Sorbonne Université, INSERM, CNRS, 75012 Paris, France., Guillonneau X; Institut de la Vision, Sorbonne Université, INSERM, CNRS, 75012 Paris, France., Sennlaub F; Institut de la Vision, Sorbonne Université, INSERM, CNRS, 75012 Paris, France.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2022 Jan 08; Vol. 23 (2). Date of Electronic Publication: 2022 Jan 08.

A Preservative-Free Combination of Sodium Hyaluronate and Trehalose Improves Dry Eye Signs and Symptoms and Increases Patient Satisfaction in Real-Life Settings: The TEARS Study.

Autor: Mateo-Orobia, Antonio J.¹ (AUTHOR) catarata@comz.org, Farrant, Sarah² (AUTHOR), Del-Prado-Sanz, Eduardo³ (AUTHOR), Blasco-Martínez, Alejandro⁴ (AUTHOR), Idoipe-Corta, Miriam¹ (AUTHOR), Lafuente-Ojeda, Noelia¹ (AUTHOR), Pablo-Júlvez, Luis E.¹ (AUTHOR)

Publikováno v: Ophthalmology & Therapy. Dec2024, Vol. 13 Issue 12, p3123-3134. 12p.